Tag: Weight Management
-
NHS Warns Mounjaro Users About Interactions with Oral Medications
Overview: What the NHS is warning about The NHS has issued guidance for people using Mounjaro (tirzepatide) as part of its growing role in weight management. While the diabetes and obesity drug can help suppress appetite by delaying gastric emptying, this very mechanism can also alter how quickly and effectively oral medications are absorbed. In…
-
A Safer Way to Make Cells Burn More Calories: A Breakthrough in Metabolism
New Hope in the Battle Against Obesity Obesity remains a global health challenge, linked to diabetes, heart disease, and certain cancers. For years, researchers have pursued methods to raise the body’s energy expenditure—how many calories our cells burn—without relying on injections or risky drugs. A recent breakthrough suggests a safer approach to tipping the metabolic…
-
What Happens When People Stop GLP-1 Weight Drugs? A Grim Return of Hunger and Pounds
The Challenge of Weaning Off GLP-1 Medications Across the world, many individuals who achieved notable weight loss with GLP-1 agonists like Ozempic report a troubling pattern when they try to discontinue treatment. First popularized as a diabetes medication, GLP-1 drugs have become widely used off-label for weight management, helping people shed pounds by reducing appetite…
-
January Reset: Reversing Weight Gain with Professor Donal O’Shea
Introduction: A Proven Expert in a Time-Pressed Moment This week on The Real Health podcast, listeners are treated to insights from Professor Donal O’Shea, the HSE lead for obesity. In a resurfaced vault episode, Professor O’Shea shares practical strategies for reversing weight gain, especially relevant as many people kick off the new year with a…
-
Beyond weight loss: How Semaglutide cuts heart risk faster than the scale moves
Introduction: The heart benefits most patients want Semaglutide, a medication originally developed to help manage type 2 diabetes and support weight loss, has found a broader role in cardiovascular health. While the scale may take time to show dramatic change, researchers and clinicians are discovering that semaglutide can lower heart risk parameters sooner than expected.…
-
Real Health January Reset: Reversing Weight Gain with Professor Donal O’Shea
Overview The Real Health January Reset episode brings together Professor Donal O’Shea, a leading voice in obesity research and the HSE’s national lead for obesity, to unpack practical strategies for reversing weight gain. In this archived conversation, Professor O’Shea shares clear, evidence-based guidance on how to reset your eating patterns after the festive season, how…
-
Rethinking Fat Loss: Why Exercise Alone Won’t Burn Most Fat—and What Actually Works
Rethinking Fat Loss: The Role of Exercise in a Sustainable Plan For years, the conventional wisdom has been clear: burn more calories through movement, and the rest will follow. In reality, the relationship between exercise and fat loss is more nuanced. While exercise offers essential health benefits and can help create a caloric deficit, relying…
-
NHS Prevention Scheme Slashes Type 2 Diabetes Risk by a Third
How a NHS prevention program helps cut diabetes risk In a landmark demonstration of preventive health care, an NHS lifestyle intervention is showing promising results in reducing the risk of developing type 2 diabetes. The program targets adults who are at high risk due to factors like excess weight, family history, and impaired glucose levels,…
-
Citrus Burn in Scientific Debate on Metabolic Health and Dietary Support
Overview: Citrus Burn in the broader metabolic health conversation The supplement Citrus Burn has emerged in both consumer discussions and scientific debates about metabolic health, weight management, and dietary strategies. With rising interest in natural interventions and evidence-based wellness, Citrus Burn is often cited as part of a larger ecosystem of dietary supplements that people…
-
Let Them Eat Cake: The Fix for Obesity — A Wealthy Promise?
The Promise of GLP-1 Drugs: A Medical Breakthrough with a Price Tag The emergence of GLP-1 receptor agonists, including semaglutide-based medications, has marked a turning point in the battle against obesity. These drugs don’t just suppress appetite; they alter metabolism in ways that can significantly reduce body weight and improve associated health risks. Yet the…